The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1619
ISSUE1619
March 8, 2021
Oliceridine (Olinvyk) - A New Opioid for Severe Pain
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Oliceridine (Olinvyk) - A New Opioid for Severe Pain
March 8, 2021 (Issue: 1619)
Oliceridine (Olinvyk - Trevena), an IV opioid agonist,
has been approved by the FDA for management of
acute pain severe enough to require an opioid and for
which alternative treatment options are inadequate.
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.